Laura Shawver, Ph.D.
DirectoratRelay Therapeutics· In proxies 2023–2025
Laura Shawver, Ph.D. sits on 5 public boards.
Boards1
- Relay TherapeuticsDirector · 7 yr on the boardIndependentAudit, Research and Development—Paid as an executive
'%20fill='%23FEFEFE'%3e%3cpath%20d='M67.7444739,25%20L33.1043073,38.2478027%20L34.7958615,41.1131448%20L41.0490807,51.7151219%20L29.0986607,51.7151219%20L28,54.6065381%20L57.1428867,79%20L60.0675871,77.3612019%20L46.8800441,55.0029363%20L63.0277166,55.0032886%20L63.8216155,51.7151219%20L70,26.9178624%20L67.7444739,25%20Z%20M38,39.9222264%20L66,29%20L60.3908123,52%20L44.9725093,52%20L38,39.9222264%20Z%20M34,55%20L43.1090246,55%20L52,70%20L34,55%20Z'%20id='Fill-1-Copy'/%3e%3c/g%3e%3c/g%3e%3c/svg%3e)
Board seats come from each company's latest proxy statement.
Experience
- Relay TherapeuticsPublic company · 3 yr
- Director2023 – Present · 3 yrStock in role +37%
- Bright Peak TherapeuticsPublic company
- Director? – PresentNo stock prices for these years
- Cleave Therapeutics, Inc.Public company
- Director? – PresentNo stock prices for these years
- Dovetail TherapeuticsPublic company
- Director? – PresentNo stock prices for these years
- Nkarta, Inc.Public company
- Director? – PresentNo stock prices for these years
Roles come from the proxy statements of each company.
Activity
No new filings about this person in the feed.
Two people shown as one, or a wrong number?